rs2516739
|
|
Longevity
|
|
0.800 |
GeneticVariation
|
GWASDB |
Joint influence of small-effect genetic variants on human longevity.
|
20834067 |
2010 |
rs2516739
|
|
Longevity
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Joint influence of small-effect genetic variants on human longevity.
|
20834067 |
2010 |
rs137854117
|
|
TUBEROUS SCLEROSIS 2 (disorder)
|
T |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs137854360
|
|
TUBEROUS SCLEROSIS 2 (disorder)
|
T |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs150766139
|
|
Neoplastic Syndromes, Hereditary
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs150766139
|
|
Carcinoma of larynx
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs150766139
|
|
Intracranial Meningioma
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs150766139
|
|
Breast Carcinoma
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs150766139
|
|
FAMILIAL ADENOMATOUS POLYPOSIS 3
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs150766139
|
|
Adenocarcinoma of large intestine
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs2516739
|
|
Body mass index
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs372946560
|
|
FAMILIAL ADENOMATOUS POLYPOSIS 3
|
T |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs397515020
|
|
TUBEROUS SCLEROSIS 2 (disorder)
|
GT |
0.700 |
CausalMutation
|
CLINVAR |
Extensive acrochordons and pancreatic islet-cell tumors in tuberous sclerosis associated with TSC2 mutations.
|
16835931 |
2006 |
rs45512692
|
|
TUBEROUS SCLEROSIS 2 (disorder)
|
T |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs150766139
|
|
Colorectal Carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
The carrier of c.268C>T (p.Q90*) and 550-1G>A was diagnosed with CRC and meningioma at ages 37 and 45 respectively, being reclassified as attenuated adenomatous polyposis after the cumulative detection of 26 adenomas.
|
31227763 |
2019 |
rs150766139
|
|
Colorectal Carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
We found sufficient evidence for NTHL1 to be considered a CRC predisposition gene-members of 3 unrelated Dutch families were homozygous for inactivating p.Gln90Ter mutations; a Canadian woman with polyposis, CRC, and multiple tumors was reported to be heterozygous for the inactivating NTHL1 p.Gln90Ter/c.709+1G>A mutations; and a man with polyposis was reported to carry p.Gln90Ter/p.Gln287Ter; whereas no inactivating homozygous or compound heterozygous mutations were detected in controls.
|
27713038 |
2017 |
rs146347092
|
|
Multiple polyps
|
|
0.010 |
GeneticVariation
|
BEFREE |
We found sufficient evidence for NTHL1 to be considered a CRC predisposition gene-members of 3 unrelated Dutch families were homozygous for inactivating p.Gln90Ter mutations; a Canadian woman with polyposis, CRC, and multiple tumors was reported to be heterozygous for the inactivating NTHL1 p.Gln90Ter/c.709+1G>A mutations; and a man with polyposis was reported to carry p.Gln90Ter/p.Gln287Ter; whereas no inactivating homozygous or compound heterozygous mutations were detected in controls.
|
27713038 |
2017 |
rs150766139
|
|
Adenomatous Polyposis Coli
|
|
0.010 |
GeneticVariation
|
BEFREE |
The carrier of c.268C>T (p.Q90*) and 550-1G>A was diagnosed with CRC and meningioma at ages 37 and 45 respectively, being reclassified as attenuated adenomatous polyposis after the cumulative detection of 26 adenomas.
|
31227763 |
2019 |
rs150766139
|
|
Meningioma, benign, no ICD-O subtype
|
|
0.010 |
GeneticVariation
|
BEFREE |
The carrier of c.268C>T (p.Q90*) and 550-1G>A was diagnosed with CRC and meningioma at ages 37 and 45 respectively, being reclassified as attenuated adenomatous polyposis after the cumulative detection of 26 adenomas.
|
31227763 |
2019 |
rs150766139
|
|
Adult Meningioma
|
|
0.010 |
GeneticVariation
|
BEFREE |
The carrier of c.268C>T (p.Q90*) and 550-1G>A was diagnosed with CRC and meningioma at ages 37 and 45 respectively, being reclassified as attenuated adenomatous polyposis after the cumulative detection of 26 adenomas.
|
31227763 |
2019 |
rs150766139
|
|
Adenoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
The carrier of c.268C>T (p.Q90*) and 550-1G>A was diagnosed with CRC and meningioma at ages 37 and 45 respectively, being reclassified as attenuated adenomatous polyposis after the cumulative detection of 26 adenomas.
|
31227763 |
2019 |
rs150766139
|
|
Meningioma
|
|
0.010 |
GeneticVariation
|
BEFREE |
The carrier of c.268C>T (p.Q90*) and 550-1G>A was diagnosed with CRC and meningioma at ages 37 and 45 respectively, being reclassified as attenuated adenomatous polyposis after the cumulative detection of 26 adenomas.
|
31227763 |
2019 |
rs150766139
|
|
Multiple polyps
|
|
0.010 |
GeneticVariation
|
BEFREE |
We found sufficient evidence for NTHL1 to be considered a CRC predisposition gene-members of 3 unrelated Dutch families were homozygous for inactivating p.Gln90Ter mutations; a Canadian woman with polyposis, CRC, and multiple tumors was reported to be heterozygous for the inactivating NTHL1 p.Gln90Ter/c.709+1G>A mutations; and a man with polyposis was reported to carry p.Gln90Ter/p.Gln287Ter; whereas no inactivating homozygous or compound heterozygous mutations were detected in controls.
|
27713038 |
2017 |
rs2233518
|
|
Carcinoma of lung
|
|
0.010 |
GeneticVariation
|
BEFREE |
The NTH1 c.98G>T polymorphism rs2302172 (p = 0.02 and p = 0.02 for allele and genotype frequency between cases and controls, respectively) and the 140-17C> T variant (rs2233518) (p = 0.02 and p = 0.02 for allele and genotype frequency between cases and controls, respectively) were detected in four lung cancer cases (4 %) while the NTH1 Q131K (C391A) polymorphism was found in seven lung cancer cases (7 %) (p = 0.001 and p = 0.008, for allele and genotype frequency between cases and controls, respectively).
|
26400813 |
2015 |
rs2233518
|
|
Malignant neoplasm of lung
|
|
0.010 |
GeneticVariation
|
BEFREE |
The NTH1 c.98G>T polymorphism rs2302172 (p = 0.02 and p = 0.02 for allele and genotype frequency between cases and controls, respectively) and the 140-17C> T variant (rs2233518) (p = 0.02 and p = 0.02 for allele and genotype frequency between cases and controls, respectively) were detected in four lung cancer cases (4 %) while the NTH1 Q131K (C391A) polymorphism was found in seven lung cancer cases (7 %) (p = 0.001 and p = 0.008, for allele and genotype frequency between cases and controls, respectively).
|
26400813 |
2015 |